| BCBS Highmark NY and West NY | Programmed Death Receptor (PD-1)/ Programmed Death-Ligand (PD-L1) Blocking Antibodies | 2026-04-01 |
| BCBS Highmark NY and West NY | Carboplatin (Paraplatin) | 2026-04-01 |
| BCBS Highmark NY and West NY | Immune Globulin Therapy | 2026-04-01 |
| BCBS Highmark NY and West NY | Treatment of Spinal Muscular Atrophy | 2026-04-01 |
| BCBS Highmark NY and West NY | Denosumab (Prolia, Xgeva) and Denosumab Biosimilars | 2026-04-01 |
| BCBS Highmark NY and West NY | Intravesicular Gemcitabine (Inlexzo) | 2026-04-01 |
| BCBS California | Investigational Services | 2026-04-01 |
| UHC UMR Medical and Drug | Respiratory Interleukins (Cinqair®, Fasenra®, & Nucala®) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Respiratory Interleukins (Cinqair®, Fasenra®, & Nucala®) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Cardiovascular Disease Risk Tests – Commercial and Individual Exchange Medical Policy | 2026-04-01 |